V

Varian

Tech-enabled radiation oncology hardware and software

Head of Customer Advocacy

Full-TimeUpdated on 10/16/2026
No salary listed
Expert
Bachelor's
Remote in UK
Remote
Growth & MarketingProduct Marketing

About the job

Requirements
  • A bachelor's degree in Business, Marketing, Healthcare Administration, Life Sciences, Radiotherapy, or a related field is required.
  • Experience in customer advocacy, product marketing, healthcare marketing, commercialization, clinical strategy, or related functions is required.
  • Experience working within healthcare technology, oncology, digital health, SaaS, clinical software, or healthcare services organizations is required.
  • Demonstrated experience leading advisory boards, customer advocacy programs, or evidence-generation initiatives is required.
  • Strong executive presence and the ability to engage senior healthcare leaders, clinicians, and strategic customers are required.
  • Communication, facilitation, stakeholder management, and strategic planning skills are required.
Responsibilities
  • Develop and execute the customer advocacy strategy across the Digital Oncology portfolio.
  • Build and maintain a network of customer champions, references, and advocates across oncology provider organizations, health systems, and strategic accounts.
  • Establish scalable advocacy programs that support commercialization, customer engagement, and market differentiation.
  • Ensure the voice of the customer is represented across marketing, product, and commercial initiatives.
  • Own the strategy, governance, planning, and execution of Digital Oncology advisory boards.
  • Develop annual engagement plans aligned with product strategy, market priorities, and customer needs.
  • Recruit, engage, and maintain relationships with key oncology stakeholders, clinical leaders, and executive customers.
  • Partner with regional sales and marketing teams to identify strategic customer participants and ensure global representation across advisory activities.
  • Translate customer feedback into actionable recommendations for Product Marketing, Product Management, Commercial Strategy, and Executive Leadership.
  • Lead initiatives to gather customer-driven clinical, operational, and business evidence supporting Digital Oncology solutions and services.
  • Partner with clinical, product, and commercial teams to identify evidence-generation opportunities.
  • Develop customer case studies, workflow analyses, outcomes assessments, value realization studies, and return-on-investment frameworks.
  • Create and maintain an evidence repository supporting commercialization, customer engagement, and market positioning.
  • Establish and manage processes for validating product and marketing claims.
  • Partner with Legal, Clinical, Regulatory, Product, and Marketing teams to ensure external claims are evidence-based, supportable, and compliant.
  • Maintain supporting documentation and governance processes for commercial messaging and customer-facing materials.
  • Ensure alignment between customer outcomes, product capabilities, and market positioning.
  • Lead the development and operation of customer consortiums and collaborative innovation programs.
  • Define program objectives, governance models, participation frameworks, and engagement strategies.
  • Facilitate collaboration between customers and internal stakeholders to advance innovation, workflow optimization, and evidence generation.
  • Capture and disseminate insights that inform product strategy, commercialization priorities, and customer success initiatives.
  • Develop programs that increase customer participation in speaking engagements, conferences, publications, webinars, advisory activities, and industry events.
  • Partner with Communications and Marketing teams to amplify customer stories and thought leadership opportunities.
  • Support executive and customer-facing events by identifying advocacy opportunities and customer participation strategies.
  • Partner with Sales Operations and Customer Engagement teams to define the strategic objectives, content, and customer outcomes for VIP customer visits, Customer Experience Center engagements, and executive briefing programs.
  • Ensure customer engagement experiences reinforce product value, market differentiation, and long-term advocacy development.
  • Identify opportunities to convert executive customer engagements into advocacy, evidence generation, and strategic partnership opportunities.
  • Collaborate with Product Marketing to ensure customer insights and evidence support positioning, messaging, launches, and commercialization strategies.
  • Partner with Commercial Strategy to align advocacy programs with growth initiatives and strategic priorities.
  • Work with Product Management to incorporate customer feedback into product planning and roadmap discussions.
  • Coordinate with Regional Marketing and Regional Sales teams to identify customer advocacy opportunities, recruit program participants, and activate customer success stories across global markets.
  • Partner with Strategic Partnership Managers to identify, engage, and develop strategic customer relationships that support consortiums, collaborative innovation programs, advisory boards, and evidence-generation initiatives.
  • Support Strategic Partnership Managers in cultivating executive customer relationships that advance customer value and broader business objectives.
  • Coordinate with Communications, Clinical, and Executive Leadership teams to maximize the impact of customer advocacy initiatives and thought leadership programs.
Desired Qualifications
  • Experience in oncology, radiation oncology, medical oncology, or healthcare workflow technology.
  • Familiarity with clinical evidence generation, outcomes research, value realization programs, or claims substantiation processes.
  • Experience supporting SaaS, on-premise software, managed services, or healthcare technology solutions.
  • Experience managing customer reference programs, thought leadership initiatives, consortiums, or collaborative innovation programs.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.